REQUEST A DEMO
Total
USD $0.00
Search more companies

Jelgavas Pils Aptieka SIA (Latvia)

Main Activities: Pharmacies and Drug Stores
Full name: Jelgavas Pils Aptieka SIA Profile Updated: May 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Jelgavas Pils Aptieka SIA is an enterprise based in Latvia. Its main office is in Jelgava. The company operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on June 10, 1994. It currently has a total number of 20 (2023) employees. From the latest financial highlights, Jelgavas Pils Aptieka SIA reported a net sales revenue drop of 2.6% in 2025. During that time, Jelgavas Pils Aptieka SIA’s total assets grew by 16.87%. Jelgavas Pils Aptieka SIA’s net profit margin increased by 3.89% in 2025.

Headquarters
Akademijas iela 2
Jelgava; Jelgavas municipality; Postal Code: 3001

Contact Details: Purchase the Jelgavas Pils Aptieka SIA report to view the information.

Basic Information
Total Employees:
Purchase the Jelgavas Pils Aptieka SIA report to view the information.
Registered Capital:
Purchase the Jelgavas Pils Aptieka SIA report to view the information.
Financial Auditors:
Purchase the Jelgavas Pils Aptieka SIA report to view the information.
Incorporation Date:
June 10, 1994
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Jelgavas Pils Aptieka SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.6%
Total Operating Revenue
-2.6%
Operating Profit
83.58%
EBITDA
83.58%
Net Profit/Loss for the Period
73.78%
Total Assets
16.87%
Total Equity
11.45%
Operating Profit Margin
4.61%
Net Profit Margin
3.89%
Return on Equity (ROE)
7.25%
Quick Ratio
-0.44%
Cash Ratio
-0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?